全文获取类型
收费全文 | 878篇 |
免费 | 47篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 47篇 |
妇产科学 | 27篇 |
基础医学 | 84篇 |
口腔科学 | 38篇 |
临床医学 | 95篇 |
内科学 | 211篇 |
皮肤病学 | 16篇 |
神经病学 | 31篇 |
特种医学 | 116篇 |
外科学 | 118篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 63篇 |
眼科学 | 3篇 |
药学 | 59篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 50篇 |
出版年
2023年 | 8篇 |
2022年 | 11篇 |
2021年 | 8篇 |
2019年 | 10篇 |
2018年 | 15篇 |
2017年 | 13篇 |
2016年 | 15篇 |
2015年 | 23篇 |
2014年 | 23篇 |
2013年 | 42篇 |
2012年 | 23篇 |
2011年 | 25篇 |
2010年 | 24篇 |
2009年 | 23篇 |
2008年 | 15篇 |
2007年 | 46篇 |
2006年 | 25篇 |
2005年 | 18篇 |
2004年 | 10篇 |
2003年 | 15篇 |
2002年 | 15篇 |
2001年 | 15篇 |
2000年 | 17篇 |
1999年 | 20篇 |
1998年 | 48篇 |
1997年 | 52篇 |
1996年 | 62篇 |
1995年 | 47篇 |
1994年 | 30篇 |
1993年 | 33篇 |
1992年 | 8篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 19篇 |
1988年 | 29篇 |
1987年 | 26篇 |
1986年 | 15篇 |
1985年 | 18篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 10篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1975年 | 5篇 |
1971年 | 4篇 |
1968年 | 7篇 |
1967年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有973条查询结果,搜索用时 15 毫秒
81.
Immunoadsorption for coagulation factor inhibitors 总被引:1,自引:0,他引:1
J Uehlinger ; GR Button ; J McCarthy ; A Forster ; R Watt ; LM Aledort 《Transfusion》1991,31(3):265-269
Inhibitors to coagulation factors are among the most difficult problems in the management of coagulation disorders. Most presently available therapy does not assure hemostasis. An extracorporeal immunoadsorption system, which selectively binds IgG, was used to lower inhibitor levels in eight patients on 10 occasions. In this system, separated plasma is delivered to two staphylococcal protein A-Sepharose columns, which are coupled to an elution monitor. Columns are eluted sequentially and regenerated to maximize IgG removal. Successful removal of the inhibitor was accomplished in all six hemophiliacs on seven occasions, as well as in a patient with acquired von Willebrand disease. All patients whose inhibitors were lowered to less than 10 Bethesda units achieved measurable factor levels when factor concentrate replacement was given. Immunoadsorption facilitates efficient removal of inhibitors, which allows factor replacement therapy. 相似文献
82.
DA Marcus L Scharff D Turk LM Gourley 《Cephalalgia : an international journal of headache》1997,17(8):855-862
A provocative double blind study of headache was performed using chocolate as the active agent and carob as the placebo. The chocolate and carob samples were formulated to duplicate products used in an earlier study (1) in which strong differential effects between the ability of chocolate and carob to trigger headache in migraine were shown. Sixty-three women with chronic headache (50% migraine, 37.5% tension-type, 12.5% combined migraine and tension-type) participated in the study. After 2 weeks of following a diet that restricted vasoactive amine-rich foods, each subject underwent double-blinded provocative trials with two samples of chocolate and two of carob presented in random order. Diaries were maintained by the subjects throughout the study, monitoring diet and headache. The results demonstrated that chocolate was not more likely to provoke headache than was carol in any of the headache diagnostic groups (2 (2) 0.36, p =0.83). Interestingly, these results were independent of subjects' beliefs regarding the role of chocolate in the instigation of headache (2 (1)=0.73, p =0.39). Headache diagnosis and the concomitant use of additional vasoactive amine-containing foods were also not associated with chocolate acting as a headache trigger. Thus, contrary to the commonly held belief of patients and physicians, chocolate does not appear to play a significant role in triggering headaches in typical migraine, tension-type, or combined headache sufferers. 相似文献
83.
84.
85.
Aníbal E Carbajo Carolina Vera Paula LM González 《International journal of health geographics》2009,8(1):44-10
Background
Oligoryzomys longicaudatus (colilargo) is the rodent responsible for hantavirus pulmonary syndrome (HPS) in Argentine Patagonia. In past decades (1967–1998), trends of precipitation reduction and surface air temperature increase have been observed in western Patagonia. We explore how the potential distribution of the hantavirus reservoir would change under different climate change scenarios based on the observed trends. 相似文献86.
Open reduction and internal fixation is the treatment of choice in distal humerus fractures. The aims of the treatment are
to obtain anatomic reconstruction and restoration of the elbow’s geometry followed by stable internal fixation that allows
immediate rehabilitation. The plates are pre-contoured to fit the natural anatomy of the elbow and in the case of complex
fractures they provide a guide for the anatomic restoration of the distal humerus. The two plates are placed parallel with
the screws locked together by interdigitation creating a fixed angle in the distal fragments that provides stability to the
entire distal humerus. Using this method we obtained good results according to the Mayo Elbow Performance Score (MEPS) and
we are able to reduce the incidence of complications. Our experience shows also that it can be useful to obtain an anatomical
reduction of distal humeral fractures using the pre-contoured plates in a parallel position recovering the anatomical antiversion
of the articular surface. 相似文献
87.
Paola Circosta Chiara Donini Susanna Gallo Lidia Giraudo Loretta Gammaitoni Ramona Rotolo Federica Galvagno Sonia Capellero Marco Basiricò Monica Casucci Massimo Aglietta Ivana Ferrero Franca Fagioli Alessandro Cignetti Fabrizio Carnevale-Schianca Valeria Leuci Dario Sangiolo 《British journal of haematology》2023,200(1):64-69
Cytokine-induced killer lymphocytes (CIK) are a promising alternative to conventional donor lymphocyte infusion (DLI), following allogeneic haematopoietic cell transplantation (HCT), due to their intrinsic anti-tumour activity and reduced risk of graft-versus-host disease (GVHD). We explored the feasibility, anti-leukaemic activity and alloreactive risk of CIK generated from full-donor chimaeric (fc) patients and genetically redirected by a chimeric antigen receptor (CAR) (fcCAR.CIK) against the leukaemic target CD44v6. fcCAR.CIK were successfully ex-vivo expanded from leukaemic patients in complete remission after HCT confirming their intense preclinical anti-leukaemic activity without enhancing the alloreactivity across human leukocyte antigen (HLA) barriers. Our study provides translational bases to support clinical studies with fcCAR.CIK, a sort of biological bridge between the autologous and allogeneic sources, as alternative DLI following HCT. 相似文献
88.
89.
90.